Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
People who take GLP-1s may experience common side effects including nausea, vomiting, gastrointestinal issues, and headaches
A revolution in obesity treatment
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
GLP medications slow down digestion, reducing the pace at which your body processes food
When activated, these sensors trigger GLP-1 secretion
Contact Noor Medical Spa or schedule your consultation and learn if B12 injections are right for you
US$ 24.49
US$ 24.76
US$ 29.22
US$ 29.36
